SOPH Stock Summary and Trading Ideas (Sophia Genetics SA - | NASDAQ:SOPH)

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Sophia Genetics SA - trades on the NASDAQ stock market under the symbol SOPH.

As of November 11, 2026, SOPH stock price declined to $7.47 with 809,608 million shares trading.

SOPH has a beta of 1.41, meaning it tends to be more sensitive to market movements. SOPH has a correlation of 0.10 to the broad based SPY ETF.

SOPH has a market cap of $626.28 million. This is considered a Small Cap stock.

Last quarter Sophia Genetics SA - reported $24 million in Revenue and -$.24 earnings per share. This beat revenue expectation by $266,920 and missed earnings estimates by -$.05.

In the last 3 years, SOPH traded as high as $8.98 and as low as $2.58.

The top ETF exchange traded funds that SOPH belongs to (by Net Assets): ONEQ, GWX, MEDI, GNMX.

SOPH has outperformed the market in the last year with a price return of +71.6% while the SPY ETF gained +12.6%. However, in the short term, SOPH had mixed performance relative to the market. It has underperformed in the last 3 months, returning -2.7% vs -1.5% return in SPY. But in the last 2 weeks, SOPH shares have fared better than the market returning -1.0% compared to SPY -1.3%.

SOPH support price is $7.50 and resistance is $8.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SOPH shares will trade within this expected range on the day.